Insights

Innovative Biocontrol Technology AmebaGone utilizes soil-dwelling amoebae as a novel biocontrol method to combat persistent bacterial infections across agriculture, medical, and industrial sectors, offering a unique alternative to traditional chemical disinfectants and antibiotics.

Expanding Market Applications The company is targeting diverse markets including crop protection, medical device sterilization, wound treatment, and food safety, which presents multiple avenues for customized solutions and cross-sector sales opportunities.

Strong Funding Momentum Having secured a $10 million Series A funding round and earlier seed investment, AmebaGone shows significant investor confidence, indicating strong growth potential and increasing capacity for large-scale commercial partnerships.

Growth and Revenue Potential With current revenues estimated between one and ten million dollars, the company presents a promising opportunity for partners to expand adoption of its biocontrol technologies in markets heavily reliant on effective bacterial management.

Strategic Industry Positioning Operating within the competitive biotechnology research space and with notable competitors like Roche and Johnson & Johnson, AmebaGone's focus on innovative, eco-friendly bacterial solutions positions it favorably for partnerships with large pharma, agritech, and industrial firms seeking sustainable alternatives.

Similar companies to AmebaGone, Inc.

AmebaGone, Inc. Tech Stack

AmebaGone, Inc. uses 8 technology products and services including Lucide, Sirvoy, React, and more. Explore AmebaGone, Inc.'s tech stack below.

  • Lucide
    Font Scripts
  • Sirvoy
    Hotel Management
  • React
    Javascript Frameworks
  • Lodash
    Javascript Libraries
  • Priority Hints
    Performance
  • Node.js
    Programming Languages
  • HTTP/3
    Web & Portal Technology
  • Google Analytics
    Web Analytics

AmebaGone, Inc.'s Email Address Formats

AmebaGone, Inc. uses at least 1 format(s):
AmebaGone, Inc. Email FormatsExamplePercentage
FLast@amebagone.comJDoe@amebagone.com
50%
FLast@amebagone.comJDoe@amebagone.com
50%

Frequently Asked Questions

Where is AmebaGone, Inc.'s headquarters located?

Minus sign iconPlus sign icon
AmebaGone, Inc.'s main headquarters is located at 510 Charmany Drive, Suite 58 Madison, Wisconsin 53719, US. The company has employees across 1 continents, including North America.

What is AmebaGone, Inc.'s official website and social media links?

Minus sign iconPlus sign icon
AmebaGone, Inc.'s official website is amebagone.com and has social profiles on LinkedInCrunchbase.

What is AmebaGone, Inc.'s SIC code NAICS code?

Minus sign iconPlus sign icon
AmebaGone, Inc.'s SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does AmebaGone, Inc. have currently?

Minus sign iconPlus sign icon
As of October 2025, AmebaGone, Inc. has approximately 5 employees across 1 continents, including North America. Key team members include Founder: M. F.Director Of Research & Development: M. W.Manager Operations: C. T.. Explore AmebaGone, Inc.'s employee directory with LeadIQ.

What industry does AmebaGone, Inc. belong to?

Minus sign iconPlus sign icon
AmebaGone, Inc. operates in the Biotechnology Research industry.

What technology does AmebaGone, Inc. use?

Minus sign iconPlus sign icon
AmebaGone, Inc.'s tech stack includes LucideSirvoyReactLodashPriority HintsNode.jsHTTP/3Google Analytics.

What is AmebaGone, Inc.'s email format?

Minus sign iconPlus sign icon
AmebaGone, Inc.'s email format typically follows the pattern of FLast@amebagone.com. Find more AmebaGone, Inc. email formats with LeadIQ.

When was AmebaGone, Inc. founded?

Minus sign iconPlus sign icon
AmebaGone, Inc. was founded in 2010.

AmebaGone, Inc.

Biotechnology ResearchUnited States2-10 Employees

AmebaGone uses naturally occurring, soil-dwelling amoebae (Dictyostelids) as drugs and disinfectants in agriculture, medicine, and industry. The amoebae kill bacteria, antibiotic-resistant or not, by consuming them as their food source. Additionally, the amoebae can break down biofilms and consume the bacteria within. Biofilms pose significant problems for agriculture, medicine, and industry because conventional antimicrobials and disinfectants have little to no effect against them. AmebaGone, Inc. is developing proprietary technologies that use a novel biocontrol method to destroy persistent bacterial infections. 

Potential applications include:
1) Reduction in agricultural disease such as fire blight in apples and soft rot in potatoes
2) Sterilization of medical devices, such as protection against Staphylococcus epidermidis
3) Treatment of wounds and infections from common pathogens such as Pseudomonas aeruginosa and Staphylococcus aureus, including MRSA
4) Protection of food-processing equipment and food itself from Escherichia coli, Salmonella enterica, Listeria monocytogenes, and other industrial contaminants.

Section iconCompany Overview

Headquarters
510 Charmany Drive, Suite 58 Madison, Wisconsin 53719, US
SIC Code
8733 - Noncommercial Research Organizations
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2010
Employees
2-10

Section iconFunding & Financials

  • $1M$10M

    AmebaGone, Inc.'s revenue is estimated to be in the range of $1M$10M

Section iconFunding & Financials

  • $1M$10M

    AmebaGone, Inc.'s revenue is estimated to be in the range of $1M$10M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.